newark calif april 30 2015 globe newswir stemcel inc nasdaqstem lead stem cell compani develop commerci novel cellbas therapeut tool use stem cellbas research drug discoveri announc today releas financi result first quarter 2015 market close tuesday may 5 stemcel host confer call webcast discuss result updat busi 130 pm pacif daylight time 430 pm eastern daylight time day interest parti invit listen call internet access investor section compani websit webcast particip allot extra time webcast begin regist necessari download instal audio softwar eventq1 2015 financi result confer call webcast datetuesday may 5 pm pdt 430 pm edtliv archiv version webcast avail replay compani websit begin approxim two hour follow conclus live call continu period 30 day stemcel incstemcel inc current engag clinic develop platform technolog hucnssc cell purifi human neural stem cell potenti treatment disord central nervous system cnsinterim data compani phase iii clinic trial thorac spinal cord injuri sci show measur gain involv multipl sensori modal segment includ convers 2 7 patient enrol studi complet injuri ai convert incomplet injuri ai b posttranspl enrol recent commenc compani phase ii clinic trial cervic sci stemcel inc also complet enrol treatment phase iii clinic trial geograph atrophi agerel macular degener gaamd sever form dri amd lead caus blind elder base upon interim result subject twelv month data compani report 70 percent reduct rate diseas progress compar control untreat eye 65 percent reduct rate diseas progress compar expect natur histori diseas phase clinic trial pelizaeusmerzbach diseas pmd fatal myelin disord children compani show preliminari evid progress durabl donorderiv myelin four patient transplant hucnssc cellsfurth inform stemcel inc avail statement histor fact text press releas constitut forwardlook statement within mean us secur law subject safe harbor creat therein forwardlook statement speak date news releas compani undertak updat forwardlook statement reflect event circumst occur date hereof statement reflect manag current view base certain assumpt may may ultim prove valid compani actual result may vari materi contempl forwardlook statement due risk uncertainti compani subject includ describ head risk factor compani annual report form 10k year endeddecemb 31 subsequ report form 10q 8k contact greg schiffmanstemcel incchief financi evansrusso 8454262 